Development of Eglin c as a drug: pharmacokinetics.

[1]  J. Bieth,et al.  Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G. , 1987, Biological chemistry Hoppe-Seyler.

[2]  G. Snider,et al.  Effect of varying the time interval between intratracheal administration of eglin-c and human neutrophil elastase on prevention of emphysema and secretory cell metaplasia in hamsters. With observations on the fate of eglin-c and the effect of repeated instillations. , 1986, The American review of respiratory disease.

[3]  H. Fritz,et al.  Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors. , 1986, Biological chemistry Hoppe-Seyler.

[4]  G. Snider,et al.  Eglin-c, a polypeptide derived from the medicinal leech, prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia in the hamster. , 1985, The American review of respiratory disease.

[5]  A. M. Lefer,et al.  Beneficial effects of a neutral protease inhibitor in traumatic shock. , 1985, Pharmacological research communications.

[6]  P. Sieber,et al.  A large fragment approach to DNA synthesis: total synthesis of a gene for the protease inhibitor eglin c from the leech Hirudo medicinalis and its expression in E. coli. , 1984, Nucleic acids research.

[7]  J. Chang,et al.  Sequence determination of eglin C using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation. , 1983, Analytical biochemistry.

[8]  M. Eulitz,et al.  Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[9]  K. Ohlsson,et al.  Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. , 1977, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[10]  H. Tschesche.  Proteinases in Inflammation and Tumor Invasion , 1986 .

[11]  M. Siebeck,et al.  Proteinase inhibitor therapy of severe inflammation in pigs: First results with eglin, a potent inhibitor of granulocyte elastase and cathepsin G. , 1986 .